Award
Delivery Order #SPE2DR26FMKN7
Delivery Order for Midazolam Hydrochloride to DMS Pharmaceutical Group
Buyer
Defense Logistics Agency
Award Amount
$8.50
Ceiling
$8.50
Awarded
March 09, 2026
Period of Performance
Mar 09, 2026 – Mar 10, 2026
Identifier
SPE2DR26FMKN7
NAICS
424210
This award represents a delivery order contract issued to DMS Pharmaceutical Group Inc., a company specializing in pharmaceutical products and services. The contract involves the procurement of Midazolam Hydrochloride, a critical pharmaceutical product used in various medical treatments. The order is part of a broader indefinite delivery vehicle (IDV) contract aimed at supporting the Pharmaceutical PV Division, indicating its strategic importance for healthcare supply operations. The contract's scope includes the timely delivery of the specified pharmaceutical product to a designated location in Park Ridge, Illinois. This delivery order is likely a competitive follow-up to the existing IDV contract with DMS Pharmaceutical Group, ensuring continuity in acquiring essential pharmaceuticals. The contract covers a short, specific timeframe, highlighting its role as a supplementary fulfillment within an ongoing long-term agreement. Overall, this award strengthens the agency's ability to efficiently source necessary medications, thereby supporting public health initiatives.
Description
4571171636! MIDAZOLAM HYDROCHLORI